Treatment Action Campaign wins a key judgment

The newly formed fund’s board took initial governance decisions for a worldwide health partnership.

The board’s work began organizing support for country-led responses to three diseases.

Members discussed review processes, monitoring and the fund’s administrative arrangements.

The 28 January meeting established processes rather than documenting completed disease elimination.

The Constitutional Court held that restrictions on nevirapine for preventing mother-to-child transmission were unreasonable.

The ruling addressed government limits on providing nevirapine to pregnant women with HIV.

The court linked access to health services with the state’s duty to take reasonable measures.

An international consortium announced completion of the original project goals.

The essentially completed genome gave researchers a foundation for studying human variation and disease.

The announcement followed large-scale cooperation among publicly funded sequencing centers.